Microarray-based mutation analysis of 183 Spanish families with Usher syndrome

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 3, 2010, Pages 1311-1317

  Jaijo, Teresa ^a,b   Aller, Elena ^a,b   García García, Gema ^a,b   Aparisi, María J ^a   Berna, Sara ^b,c   Ávila Fernández, Almudena ^b,d   Barragán, Isabel ^b,e   Baiget, Montserrat ^b,c   Ayuso, Carmen ^b,d   Antiñolo, Guillermo ^b,e   Díaz LLopis, Manuel ^a   Külm, Maigi ^f   Beneyto, Magdalena ^a,b   Nájera, Carmen ^g   Millán, Jose M ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f Asper Biotech   (Estonia)

^g UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; FAMILY STUDY; GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GPR98 GENE; HETEROZYGOSITY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; MYO7A GENE; PCDH15 GENE; POPULATION RESEARCH; PRIORITY JOURNAL; USH1C GENE; USH1G GENE; USH2A GENE; USH3A GENE; USHER SYNDROME; ALLELE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SPAIN;

CADHERIN; CDH23 PROTEIN, HUMAN; CLRN1 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; GPR98 PROTEIN, HUMAN; MEMBRANE PROTEIN; MYOSIN; MYOSIN VIIA; NERVE PROTEIN; PCDH15 PROTEIN, HUMAN; SCLEROPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; USH1C PROTEIN, HUMAN; USH1G PROTEIN, HUMAN; USH2A PROTEIN, HUMAN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALLELES; CADHERINS; DNA MUTATIONAL ANALYSIS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENOTYPE; HUMANS; MEMBRANE PROTEINS; MUTATION; MYOSINS; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED; SPAIN; USHER SYNDROMES;

EID: 77949883035     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4085     Document Type: Article

References (53)

1. Hope CI, Bundey S, Proops D, Fielder AR. Usher syndrome in the city of Birmingham: prevalence and clinical classification. Br J Ophthalmol. 1997;81(1):46-53.
2. Rosenberg T, Haim M, Hauch AM, Parving A. The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations. Clin Genet. 1997;51:314-321.
3. Espinós C, Millán JM, Beneyto M, Nájera C. Epidemiology of Usher syndrome in Valencia and Spain. Community Genet. 1998;1(4):223-228.
4. Vernon M. Sociological and psychological factors associated with hearing loss (a review). J Speech Hear Res. 1969;12:541-563.
5. Boughman, JA; Vernon, M; Shaver KA. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J Chronic Dis. 1983;36:595-603.
6. Smith RJ, Berlin CI, Hejtmancik JF, et al. Clinical diagnosis of the Usher syndromes; Usher Syndrome Consortium. Am J Med Genet. 1994;1:50(1):32-38.
7. Weil D, Blanchard S, Kaplan J, et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature. 1995;2:374(6517):60-61.
8. Bitner-Glindzicz M, Lindley KJ, Rutland P, et al. A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet. 2000;26(1):56-60.
9. Verpy E, Leibovici M, Zwaenepoel I, et al. A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nat Genet. 2000;26(1):51-55.
10. Bolz H, von Brederlow B, Ramírez A, et al. Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nat Genet. 2001;27(1):108-112.
11. Bork JM, Peters LM, Riazuddin S, et al. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet. 2001;68(1):26-37.
12. Alagramam KN, Yuan H, Kuehn MH, et al. Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F (published correction in Hum Mol Genet 2001 Oct 15;10(22):2603). Hum Mol Genet. 2001;1:10(16):1709-1718.
13. Ahmed ZM, Riazuddin S, Bernstein SL, et al. Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F. Am J Hum Genet. 2001;69(1):25-34.
14. Weil D, El-Amraoui A, Masmoudi S, et al. Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin. Hum Mol Genet. 2003;1:12(5):463-71.
15. Eudy JD, Weston MD, Yao S, et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science. 1998;12:280(5370):1753-1757.
16. van Wijk E, Pennings RJ, te Brinke H, et al. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. Am J Hum Genet. 2004;74(4):738-744.
17. Weston MD, Luijendijk MW, Humphrey KD, Möller C, Kimberling WJ. Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II (published correction in Am J Hum Genet. 2004;74(5):1080). Am J Hum Genet. 2004;74(2):357-366.
18. Ebermann I, Scholl HP, Charbel Issa P, et al. A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss. Hum Genet. 2007;121(2):203-211.
19. Joensuu T, Hämäläinen R, Yuan B, et al. Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3 (published correction in Am J Hum Genet. 2001;69(5):1160). Am J Hum Genet. 2001;69(4):673-684.
20. Adato A, Weil D, Kalinski H, et al. Mutation profile of all 49 exons of the human myosin VIIA gene, and haplotype analysis, in Usher 1B families from diverse origins. Am J Hum Genet. 1997;61(4):813-821.
21. Janecke AR, Meins M, Sadeghi M, et al. Twelve novel myosin VIIA mutations in 34 patients with Usher syndrome type I: confirmation of genetic heterogeneity. Hum Mutat. 1999;13(2):133-140.
22. Bharadwaj AK, Kasztejna JP, Huq S, Berson EL, Dryja TP. Evaluation of the myosin VIIA gene and visual function in patients with Usher syndrome type I. Exp Eye Res. 2000;71(2):173-181.
23. Roux AF, Faugère V, Le Guédard S, et al. French Usher Syndrome Collaboration. Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%. J Med Genet. 2006;43(9):763-768.
24. Jaijo T, Aller E, Oltra S, et al. Mutation profile of the MYO7A gene in Spanish patients with Usher syndrome type I. Hum Mutat. 2006;27(3):290-291.
25. Ahmed ZM, Riazuddin S, Ahmad J, et al. PCDH15 is expressed in the neurosensory epithelium of the eye and ear and mutant alleles are responsible for both USH1F and DFNB23. Hum Mol Genet. 2003;15:12(24):3215-3223.
26. Ouyang XM, Yan D, Du LL, et al. Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population. Hum Genet. 2005;116(4):292-299.
27. Aller E, Jaijo T, Beneyto M, et al. Screening of the USH1G gene among Spanish patients with Usher syndrome. Lack of mutations and evidence of a minor role in the pathogenesis of the syndrome. Ophthalmic Genet. 2007;28(3):151-155.
28. Baux D, Larrieu L, Blanchet C, et al. Molecular and in silico analyses of the full-length isoform of usherin identify new pathogenic alleles in Usher type II patients. Hum Mutat. 2007;28(8):781-789.
29. Dreyer B, Brox V, Tranebjaerg L, et al. Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II. Hum Mutat. 2008;29(3):451.
30. Ness SL, Ben-Yosef T, Bar-Lev A, et al. Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type III. J Med Genet. 2003;40(10):767-772.
31. Aller E, Jaijo T, Oltra S, et al. Mutation screening of USH3 gene (clarin-1) in Spanish patients with Usher syndrome: low prevalence and phenotypic variability. Clin Genet. 2004;66(6):525-529.
32. Cremers FP, Kimberling WJ, Külm M, et al. Development of a genotyping microarray for Usher syndrome. J Med Genet. 2007;44(2):153-160.
33. Jaijo T, Aller E, Beneyto M, et al. MYO7A mutation screening in Usher syndrome type I patients from diverse origins. J Med Genet. 2007;44(3):e71.
34. Kurg A, Tonisson N, Georgiou I, et al. Arrayed primer extension solid-phase four-color DNA resequencing and mutation detection technology. Genet Test. 2000;4:1-7.
35. Tonisson N, Zernant J, Kurg A, et al. Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene. Proc Natl Acad Sci U S A. 2002;99:5503-5508.
36. Tonisson N, Kurg A, Kaasik K, Lohmussaar E, Metspalu A. Unravelling genetic data by arrayed primer extension. Clin Chem Lab Med. 2000;38:165-170.
37. Jaakson K, Zernant J, Külm M, et al. Genotyping microarray (gene chip) for the ABCR (ABCA4) gene. Hum Mutat. 2003;22:395-403.
38. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion (published correction in Hum Mutat 2002 Nov;20(5):403). Hum Mutat. 2000;15(1):7-12.
39. Oshima A, Jaijo T, Aller E, et al. Mutation profile of the CDH23 gene in 56 probands with Usher syndrome type I. Hum Mutat. 2008;29(6):E37-E46.
40. Ahmed ZM, Riazuddin S, Riazuddin S, Wilcox ER. The molecular genetics of Usher syndrome (review). Clin Genet. 2003;63(6):431-444.
41. Astuto LM, Bork JM, Weston MD, et al. CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet. 2002;71(2):262-275.
42. Bernal S, Ayuso C, Antiñolo G, et al. Mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa: high prevalence and phenotypic variation. J Med Genet. 2003;40(1):e8.
43. Wagenaar M, van Aarem A, Huygen P, Pieke-Dahl S, Kimberling W, Cremers C. Hearing impairment related to age in Usher syndrome types 1B and 2A. Arch Otolaryngol Head Neck Surg. 1999;125(4):441-445.
44. Pennings RJ, Huygen PL, Weston MD, et al. Pure tone hearing thresholds and speech recognition scores in Dutch patients carrying mutations in the USH2A gene. Otol Neurotol. 2003;24(1):58-63.
45. Aller E; Najera C, Millan JM, et al. Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments. Eur J Hum Genet. 2004;12, 407-410.
46. Sadeghi M, Cohn ES, Kelly WJ, Kimberling WJ, Tranebjoerg L, Möller C. Audiological findings in Usher syndrome types IIa and II (non-IIa). Int J Audiol. 2004;43(3):136-143.
47. Bernal S, Medá C, Solans T, et al. Clinical and genetic studies in Spanish patients with Usher syndrome type II: description of new mutations and evidence for a lack of genotype: phenotype correlation. Clin Genet. 2005;68(3):204-214.
48. Ben-Yosef T, Ness SL, Madeo AC, et al. A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome. N Engl J Med. 2003;24:348(17):1664-1670.
49. Liu XZ, Hope C, Walsh J, et al. Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet. 1998;63(3):909-912.
50. Seyedahmadi BJ, Rivolta C, Keene JA, Berson EL, Dryja TP. Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa. Exp Eye Res. 2004;79(2):167-173.
51. Adato A, Weston MD, Berry A, Kimberling WJ, Bonne-Tamir A. Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families. Hum Mutat. 2000;15(4):388.
52. Badano JL, Leitch CC, Ansley SJ, et al. Dissection of epistasis in oligogenic Bardet-Biedl syndrome. Nature. 2006 19;439(7074):326-330.
53. Khanna H, Davis EE, Murga-Zamalloa CA, et al. A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies. Nat Genet. Published online May 10, 2009.